S. Greggi et al., INTRAPERITONEAL TUMOR SPREAD IN LOCALLY ADVANCED CERVICAL-CARCINOMA UNDERGOING NEOADJUVANT CHEMOTHERAPY, International journal of gynecological cancer, 8(3), 1998, pp. 207-214
The prognostic significance of peritoneal tumor involvement is still u
nclear, correlations with tumor characteristics are somewhat controver
sial, and little is known about the peritoneal influence of neoadjuvan
t chemotherapy and tumor extension in patients undergoing laparotomy f
ollowing clinical response to neoadjuvant chemotherapy. In this study,
208 patients with previously untreated locally advanced cervical carc
inoma were primarily treated by neoadjuvant chemotherapy. The 183 clin
ically responsive patients underwent laparotomy and, if judged to be r
adically operable, they were submitted to radical surgery. At laparoto
my, 158 of the 183 patients (86%) were still amenable for radical surg
ery; 7 (4%) and 13 (7%) showed macroscopic and microscopic peritoneal
tumor involvement, respectively. An intraperitoneal positive cytology
was registered in 5 (3%) cases. Stage, histotype, and cervical tumor s
ize were each independent predictors of peritoneal tumor involvement u
pon logistical analysis. The 10-year survival estimate of patients wit
h no peritoneal tumor involvement was longer (72%) than that of patien
ts with peritoneal tumor involvement (17%) (P = 0.001). Multivariate a
nalysis showed that the peritoneal tumor involvement together with sta
ge, pathological parametrial involvement, and lymph node status were i
ndependently associated with overall and disease-free survival. Adenoc
arcinomas have a higher propensity to peritoneal tumor involvement tha
n squamous cell carcinomas; the incidence of atypical peritoneal cytol
ogy and, to a lesser extent, microscopic metastasis, are lower than ex
pected in patients responsive to neoadjuvant chemotherapy, suggesting
a possible effect on peritoneal tumor involvement by neoadjuvant chemo
therapy. A positive relationship exists between tumor extent and perit
oneal tumor involvement, even in a neoadjuvant chemotherapy setting. P
eritoneal tumor involvement is an independent predictor of survival, b
ut it is generally associated with other risk factors.